As medical researchers and clinicians, we are concerned about the proposed reductions in funding for the U.S. National ...

Antiamyloid therapies for Alzheimer disease recently entered clinical practice, making imaging biomarkers for Alzheimer disease even more relevant to guiding patient management. Amyloid and tau PET ...

Radiopharmaceuticals Good manufacturing practice–grade PSMA-11 and PSMA-617 were obtained from ABX. 225 Ac was produced by radiochemical extraction from 229 Th (9,10). 68 Ga was eluted from a 68 Ge/ ...

The principle of pretargeted radioimmunoimaging and therapy has been investigated over the past 30 y in preclinical and clinical settings with the aim of reducing the radiation burden of healthy ...

Journal of Nuclear Medicine May 2025, jnumed.124.268938; DOI: https://doi.org/10.2967/jnumed.124.268938 ...

In vivo visualization of inflammatory lesions has been revolutionized by PET with 18 F-FDG as a tracer and by MRI with gadolinium-labeled contrast media. Apart from other indications, 18 F-FDG PET and ...

Personalization of treatment response through the use of on-treatment biomarkers is the future of theranostics and marks a key advantage of theranostics treatments over other systemic cancer therapies ...

Large language models (LLMs) are poised to have a disruptive impact on health care. Numerous studies have demonstrated promising applications of LLMs in medical imaging, and this number will grow as ...

Journal of Nuclear Medicine June 2025, jnumed.125.269655; DOI: https://doi.org/10.2967/jnumed.125.269655 ...

Journal of Nuclear Medicine April 2025, jnumed.124.269361; DOI: https://doi.org/10.2967/jnumed.124.269361 ...

Journal of Nuclear Medicine February 2025, jnumed.124.268967; DOI: https://doi.org/10.2967/jnumed.124.268967 Cancer therapy has advanced with molecularly targeted ...